Cargando…
Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol
INTRODUCTION: Norway is one of several European countries that lacks a national value set and scoring algorithm for the EuroQol five dimensions (EQ-5D). Recent studies have found differences between countries in terms of health values or preferences for health states described by instruments such as...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295408/ https://www.ncbi.nlm.nih.gov/pubmed/32532768 http://dx.doi.org/10.1136/bmjopen-2019-034683 |
_version_ | 1783546640593846272 |
---|---|
author | Hansen, Tonya Moen Helland, Ylva Augestad, Liv Ariane Rand, Kim Stavem, Knut Garratt, Andrew |
author_facet | Hansen, Tonya Moen Helland, Ylva Augestad, Liv Ariane Rand, Kim Stavem, Knut Garratt, Andrew |
author_sort | Hansen, Tonya Moen |
collection | PubMed |
description | INTRODUCTION: Norway is one of several European countries that lacks a national value set and scoring algorithm for the EuroQol five dimensions (EQ-5D). Recent studies have found differences between countries in terms of health values or preferences for health states described by instruments such as the EQ-5D. The project aims to model a national value set for the five level version of the EQ-5D based on values elicited from a representative sample of the Norwegian adult general population in terms of region, age, sex and level of education. Using a sampling strategy supporting the collection of values for both hypothetical and experienced health states, the study will have the additional aim of assessing the feasibility of collecting experience-based values in accordance with the latest EQ-5D valuation study protocol, and comparing values with those given for hypothetical health states. METHODS AND ANALYSIS: Multistage random sampling and quota-sampling will contribute to representativeness. To increase the number of valuations of experienced health states, those with less than perfect health will be oversampled, increasing the total number of interviews from 1000 to 1300–1500. The most recent EQ-5D valuation protocol will be followed which includes computer assisted face-to-face, one-to-one interviews and use of composite time trade-off and discrete choice experiments. ETHICS AND DISSEMINATION: The study has been reviewed and found to be outside of the scope of the ethics committee and thus not in need of ethical approval. The study findings will be disseminated through peer-reviewed publications, conference presentations and summaries for key stakeholders and partners in the field. The scoring algorithms will be available for widely used statistical software. |
format | Online Article Text |
id | pubmed-7295408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-72954082020-06-19 Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol Hansen, Tonya Moen Helland, Ylva Augestad, Liv Ariane Rand, Kim Stavem, Knut Garratt, Andrew BMJ Open Health Economics INTRODUCTION: Norway is one of several European countries that lacks a national value set and scoring algorithm for the EuroQol five dimensions (EQ-5D). Recent studies have found differences between countries in terms of health values or preferences for health states described by instruments such as the EQ-5D. The project aims to model a national value set for the five level version of the EQ-5D based on values elicited from a representative sample of the Norwegian adult general population in terms of region, age, sex and level of education. Using a sampling strategy supporting the collection of values for both hypothetical and experienced health states, the study will have the additional aim of assessing the feasibility of collecting experience-based values in accordance with the latest EQ-5D valuation study protocol, and comparing values with those given for hypothetical health states. METHODS AND ANALYSIS: Multistage random sampling and quota-sampling will contribute to representativeness. To increase the number of valuations of experienced health states, those with less than perfect health will be oversampled, increasing the total number of interviews from 1000 to 1300–1500. The most recent EQ-5D valuation protocol will be followed which includes computer assisted face-to-face, one-to-one interviews and use of composite time trade-off and discrete choice experiments. ETHICS AND DISSEMINATION: The study has been reviewed and found to be outside of the scope of the ethics committee and thus not in need of ethical approval. The study findings will be disseminated through peer-reviewed publications, conference presentations and summaries for key stakeholders and partners in the field. The scoring algorithms will be available for widely used statistical software. BMJ Publishing Group 2020-06-11 /pmc/articles/PMC7295408/ /pubmed/32532768 http://dx.doi.org/10.1136/bmjopen-2019-034683 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Health Economics Hansen, Tonya Moen Helland, Ylva Augestad, Liv Ariane Rand, Kim Stavem, Knut Garratt, Andrew Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol |
title | Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol |
title_full | Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol |
title_fullStr | Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol |
title_full_unstemmed | Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol |
title_short | Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol |
title_sort | elicitation of norwegian eq-5d-5l values for hypothetical and experience-based health states based on the euroqol valuation technology (eq-vt) protocol |
topic | Health Economics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295408/ https://www.ncbi.nlm.nih.gov/pubmed/32532768 http://dx.doi.org/10.1136/bmjopen-2019-034683 |
work_keys_str_mv | AT hansentonyamoen elicitationofnorwegianeq5d5lvaluesforhypotheticalandexperiencebasedhealthstatesbasedontheeuroqolvaluationtechnologyeqvtprotocol AT hellandylva elicitationofnorwegianeq5d5lvaluesforhypotheticalandexperiencebasedhealthstatesbasedontheeuroqolvaluationtechnologyeqvtprotocol AT augestadlivariane elicitationofnorwegianeq5d5lvaluesforhypotheticalandexperiencebasedhealthstatesbasedontheeuroqolvaluationtechnologyeqvtprotocol AT randkim elicitationofnorwegianeq5d5lvaluesforhypotheticalandexperiencebasedhealthstatesbasedontheeuroqolvaluationtechnologyeqvtprotocol AT stavemknut elicitationofnorwegianeq5d5lvaluesforhypotheticalandexperiencebasedhealthstatesbasedontheeuroqolvaluationtechnologyeqvtprotocol AT garrattandrew elicitationofnorwegianeq5d5lvaluesforhypotheticalandexperiencebasedhealthstatesbasedontheeuroqolvaluationtechnologyeqvtprotocol |